UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003422
Receipt number R000004122
Scientific Title A phase II study of erlotinib/S-1 combination therapy in patients with recurrent or advanced non-small lung cancer who do not possess active EGFR mutation.(TORG0913)
Date of disclosure of the study information 2010/03/31
Last modified on 2020/11/12 10:39:53

No. Disposal Last modified on Item of update
1 Insert 2010/03/31 21:50:37
2 Update 2010/10/04 11:39:14 Name of person sending information
Organization
Division name
Address
3 Update 2011/10/07 11:36:40 Recruitment status
4 Update 2011/10/07 11:39:01 Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2014/07/18 10:49:40 Email
Email
6 Update 2020/11/12 10:39:53 Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures